3 completed, 1 active not recruiting, 1 terminated. 5 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 5 | Completed 3, Active not recruiting 1, Terminated 1 |
Follow Tbi: new trials by email Literature Review of Tbi trials Research Report on Tbi
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Intensity-Modulated Radiation Therapy - Systemic Scleroderma | Early Phase 1 | Active not recruiting | City of Hope Medical Center | 15 | 2022-02-24 | 2026-08-27 |
| Stem Cell Transplant in Patients With Severe Sickle Cell Disease Alemtuzumab, Total Body Irradiation, Sirolimus - Sickle Cell Disease | Early Phase 1 | Terminated | Kathleen Dorritie | 1 | 2018-03-29 | 2022-06-28 |
| Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis Cyclophosphamide, Filgrastim, Fludarabine Phosphate - Primary Myelofibrosis, Secondary Myelofibrosis | Early Phase 1 | Completed | M.D. Anderson Cancer Center | 3 | 2018-01-31 | 2020-10-14 |
| Intra-Osseous Co-Transplant of UCB and hMSC cyclophosphamide, fludarabine phosphate, total-body irradiation - Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Early Phase 1 | Completed | Case Comprehensive Cancer Center | 6 | 2015-07-22 | 2020-12-04 |
| Donor Stem Cell Transplantation for Congenital Immunodeficiencies Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG) - Inherited Immune Deficiencies | Early Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 48 | 2007-01-19 | 2021-05-11 |
Primary Myelofibrosis (2) · Anemia, Sickle Cell (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Myelodysplastic Syndromes (1) · Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Scleroderma, Systemic (1)
Case Comprehensive Cancer Center (1) · City of Hope Medical Center (1) · Kathleen Dorritie (1) · M.D. Anderson Cancer Center (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (5)
Elizabeth M Kang, M.D. (1) · Jeffrey Y Wong (1) · Kathleen Dorritie, MD (1) · Leland Metheny, MD (1) · Stefan O Ciurea (1)
P30CA016672 (1), P30CA043703 (1)